These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23480068)

  • 1. Advances in the design of a multipurpose fragment screening library.
    Wilde F; Link A
    Expert Opin Drug Discov; 2013 May; 8(5):597-606. PubMed ID: 23480068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
    Barelier S; Krimm I
    Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to avoid rediscovering the known.
    Kuo LC
    Methods Enzymol; 2011; 493():159-68. PubMed ID: 21371591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of fragment screening and library design.
    Siegal G; Ab E; Schultz J
    Drug Discov Today; 2007 Dec; 12(23-24):1032-9. PubMed ID: 18061882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences in fragment-based drug discovery.
    Murray CW; Verdonk ML; Rees DC
    Trends Pharmacol Sci; 2012 May; 33(5):224-32. PubMed ID: 22459076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead generation and examples opinion regarding how to follow up hits.
    Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
    Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient exploration of chemical space by fragment-based screening.
    Hall RJ; Mortenson PN; Murray CW
    Prog Biophys Mol Biol; 2014; 116(2-3):82-91. PubMed ID: 25268064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning from our mistakes: the 'unknown knowns' in fragment screening.
    Davis BJ; Erlanson DA
    Bioorg Med Chem Lett; 2013 May; 23(10):2844-52. PubMed ID: 23562240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in proteasome inhibitor discovery.
    Pevzner Y; Metcalf R; Kantor M; Sagaro D; Daniel K
    Expert Opin Drug Discov; 2013 May; 8(5):537-68. PubMed ID: 23547800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
    Vulpetti A; Dalvit C
    ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.